Part 1 - Welcome and Introduction - Ms. Rupa Sharma, AstraZeneca & Dr. M B Agarwal, Mumbai
Part 2 - Current practice & challenges in CLL testing in Indian context - Dr. Ganesh Jaishetwar
Part 3 - Personalizing First-line Treatment for Patients with CLL - Dr. Sandip Shah, Ahmedabad
Part 4 - What has changed in cytogenetics of CLL? - Dr. Renu Saxena , Delhi
Part 5 - Panel discussion - Dr. Sharat Damodar , Bengaluru
Part 6 - Importance of IGHV status & tailoring treatment in CLL - Dr. Sarjana Dutt , Delhi
Part 7 - How to improve precision of current evaluation techniques? - Dr. Neelam Varma , Chandigarh
Part 8 - Role of MRD Evaluation for Patients With CLL - Dr. Deepak Mishra, Kolkata
Part 9 - Vote of thanks - Ms. Rupa Sharma, AstraZeneca
